Delivery Order SPE2DR25D1053-SPE2DR26FT637
- Not listed
- The Defense Logistics Agency awarded a $1,702.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 22, 2025, with a completion date of September 23, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The contract performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,258.00 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Refresh Plus 0.5% eye drops (30 count). This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,290.00 for Refresh Plus 0.5% eye drops (30-unit package) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) valued at $4,034.24 on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract was issued on a firm fixed-price basis and represents a child delivery order under a larger contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $1,125.76 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit package). This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,545.63 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on July 21, 2025, with a completion date of July 22, 2025. This firm fixed price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,395.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing federal contract vehicle with DLA. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT637Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,634.78 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026, enabling the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's DLA prime vendor arrangement encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for ophthalmic products reflects the contractor's role in supporting Defense Health Agency requirements and broader federal healthcare logistics operations, consistent with its demonstrated capability to fulfill diverse medical supply needs ranging from routine pharmaceutical commodities to specialized healthcare products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 11/5/25 |